Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Prostatype Genomics AB | 32,011,872 | net | 03 Oct 2025 | tx 9+120,011,872−88,000,000 |
| BioArctic AB | 1,000 | net | 27 Apr 2023 | tx 1+1,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 03 Oct 2025 | PURCHASE | Prostatype Genomics AB | 525,000 | 0.52 SEK | |
| 04 Jun 2025 | PURCHASE | Prostatype Genomics AB | 175,000 | 4.00 SEK | |
| 03 Dec 2024 | SALE | Prostatype Genomics AB | 22,000,000 | 0.00 SEK | deriv |
| 04 Dec 2024 | SALE | Prostatype Genomics AB | 66,000,000 | 0.00 SEK | deriv |
| 10 Sept 2024 | PURCHASE | Prostatype Genomics AB | 94,000,000 | 0.05 SEK | |
| 10 May 2024 | GRANT_AWARD | Prostatype Genomics AB | 20,000,000 | 0.04 SEK | |
| 05 Jan 2024 | PURCHASE | Prostatype Genomics AB | 5,000,000 | 0.40 SEK | |
| 11 May 2023 | PURCHASE | Prostatype Genomics AB | 301,872 | 0.25 SEK | |
| 27 Apr 2023 | PURCHASE | BioArctic AB | 1,000 | 241.00 SEK | first after silence |
| 22 Nov 2021 | PURCHASE | Prostatype Genomics AB | 10,000 | 10.83 SEK |
1 purchase reported after at least 12 months of silence — most recent on 27 Apr 2023.